NGEN NervGen Pharma Corp

Watchlist

15min DelayMarket Closed Nov 19 16:00 ET

160.30MMarket Cap-6000P/E (TTM)

NervGen Pharma Corp Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2022/Q4	0.000 / 0.000	--
--	2022/Q3	0.000 / 0.000	--
--	2022/Q2	0.000 / 0.000	--
--	2021/Q4	0.000 / 0.000	--
--	2021/Q3	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2022/Q40.000 / 0.000--

--2022/Q30.000 / 0.000--

--2022/Q20.000 / 0.000--

--2021/Q40.000 / 0.000--

--2021/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

NervGen Pharma Corp: INTERIM MDA EN

Nov 14 08:01 ET

NervGen Pharma Corp: INTERIM FINANCIAL STATEMENTSREPORT EN

Nov 14 08:00 ET

NervGen Pharma Corp: INTERIM MDA EN

May 16 08:02 ET

NervGen Pharma Corp: INTERIM FINANCIAL STATEMENTSREPORT EN

May 16 08:02 ET

Overall

No Data